ATE223701T1 - Intrazelluläre verabreichung therapeutischer sustanzenmittels virosomen - Google Patents

Intrazelluläre verabreichung therapeutischer sustanzenmittels virosomen

Info

Publication number
ATE223701T1
ATE223701T1 AT95919296T AT95919296T ATE223701T1 AT E223701 T1 ATE223701 T1 AT E223701T1 AT 95919296 T AT95919296 T AT 95919296T AT 95919296 T AT95919296 T AT 95919296T AT E223701 T1 ATE223701 T1 AT E223701T1
Authority
AT
Austria
Prior art keywords
virosomes
therapeutic substances
intracellular administration
therapeutic compounds
intracellular
Prior art date
Application number
AT95919296T
Other languages
English (en)
Inventor
Jan C Wilschut
Peter Scherrer
Arcadio Chonn
Original Assignee
Inex Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inex Pharmaceutical Corp filed Critical Inex Pharmaceutical Corp
Application granted granted Critical
Publication of ATE223701T1 publication Critical patent/ATE223701T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5176—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5184—Virus capsids or envelopes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95919296T 1994-05-31 1995-05-31 Intrazelluläre verabreichung therapeutischer sustanzenmittels virosomen ATE223701T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25146994A 1994-05-31 1994-05-31
PCT/CA1995/000321 WO1995032706A1 (en) 1994-05-31 1995-05-31 Virosome-mediated intracellular delivery of therapeutic agents

Publications (1)

Publication Number Publication Date
ATE223701T1 true ATE223701T1 (de) 2002-09-15

Family

ID=22952103

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95919296T ATE223701T1 (de) 1994-05-31 1995-05-31 Intrazelluläre verabreichung therapeutischer sustanzenmittels virosomen

Country Status (7)

Country Link
EP (1) EP0762870B1 (de)
JP (1) JPH10505320A (de)
AT (1) ATE223701T1 (de)
AU (1) AU2520595A (de)
CA (1) CA2191750C (de)
DE (1) DE69528170T2 (de)
WO (1) WO1995032706A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008202A (en) 1995-01-23 1999-12-28 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
CN1200036A (zh) * 1995-09-14 1998-11-25 Lxr生物技术有限公司 含有磷脂混合物并具有抗细胞程序死亡活性的组合物
NZ332666A (en) 1996-05-08 2000-05-26 Nika Health Products Ltd Cationic virosomes having a positively charged lipid bilayer membrane with an integrated viral fusogenic peptide as genetic transfer systems for use in gene therapy
US7780962B2 (en) 1997-10-09 2010-08-24 Wellstat Biologics Corporation Treatment of neoplasms with RNA viruses
US20030044384A1 (en) 1997-10-09 2003-03-06 Pro-Virus, Inc. Treatment of neoplasms with viruses
US7470426B1 (en) 1997-10-09 2008-12-30 Wellstat Biologics Corporation Treatment of neoplasms with viruses
CN1477964A (zh) 1999-04-15 2004-02-25 应用病毒治疗肿瘤
US8147822B1 (en) 1999-09-17 2012-04-03 Wellstat Biologics Corporation Oncolytic virus
JP4497894B2 (ja) * 2003-11-07 2010-07-07 明彦 河合 物質導入剤およびその製造方法
US7964196B2 (en) 2004-05-25 2011-06-21 Chimeros, Inc. Self-assembling nanoparticle drug delivery system
PL1802746T3 (pl) 2004-10-27 2011-10-31 Crucell Switzerland Ag Cząstki wirosomu zawierające antygeny wirusa grypy i wirusa zapalenia wątroby typu B
JP2009533350A (ja) * 2006-04-07 2009-09-17 キメロス， インコーポレイテッド Ｂ細胞悪性疾患を処置するための組成物および方法
WO2010120874A2 (en) 2009-04-14 2010-10-21 Chimeros, Inc. Chimeric therapeutics, compositions, and methods for using same
CA2847888A1 (en) 2011-09-09 2013-03-14 Biomed Realty, L.P. Methods and compositions for controlling assembly of viral proteins
KR20210131991A (ko) 2018-11-14 2021-11-03 플래그쉽 파이어니어링 이노베이션스 브이, 인크. 구획-특이적 카고 전달을 위한 조성물 및 방법
JP2024532963A (ja) 2021-04-08 2024-09-11 サナ バイオテクノロジー，インコーポレイテッド Ｃｄ８特異的抗体コンストラクト及びその組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9018690D0 (en) * 1990-08-24 1990-10-10 Wellcome Found Vaccines
PL296382A1 (en) * 1991-02-02 1993-11-02 Nika Health Products Ltd Li Li Artificial membrane beads containing functionally active peptides responsible for fusion as a drug administering system
US5292524A (en) * 1991-09-06 1994-03-08 California Institute Of Technology Blood platelet loaded with diagnostic or therapeutic-containing liposome or reconstituted Sendai virus

Also Published As

Publication number Publication date
EP0762870B1 (de) 2002-09-11
EP0762870A1 (de) 1997-03-19
WO1995032706A1 (en) 1995-12-07
AU2520595A (en) 1995-12-21
CA2191750C (en) 2008-06-10
CA2191750A1 (en) 1995-12-07
DE69528170T2 (de) 2003-05-22
DE69528170D1 (de) 2002-10-17
JPH10505320A (ja) 1998-05-26

Similar Documents

Publication Publication Date Title
DE69528170D1 (de) Intrazelluläre verabreichung therapeutischer sustanzenmittels virosomen
MX9203439A (es) Una citocina mamifera, il-11
MY102472A (en) Preparation of funtional human urokinase proteins.
NO862095L (no) Farmasoeytiske preparater inneholdende vevsplasmnogenaktivitator og fremgangsmaate for deres fremstilling.
DE3680368D1 (de) Biologisch aktive fragmente von humanem antihaemophiliefaktor, methode zu ihrer herstellung und pharmazeutische praeparate.
ES2059729T3 (es) Preparado farmaceutico de liberacion controlada y metodo para producir el mismo.
NO962791L (no) Preparater inneholdende nukleinsyrer, deres fremstilling og anvendelse
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
NO883229L (no) Nye benzimidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat inneholdende slike derivater.
NO862096L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator.
DK0539479T3 (da) Heterocykliske forbindelser
EP1105157A4 (de) Protein-verabreichungssystem, das dem menschlichen papillomavirus ähnliche partikel benützt.
DE69534633D1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
FR2732978B1 (fr) Vecteur viral recombinant, composition pharmaceutique le contenant et cellules transformees correspondantes
ATE341339T1 (de) Zusammensetzungen von rekombinanten papillomavirus vakzinen
DK0984983T3 (da) Modulatorer af intracellulære inflammations-, celledöds- og celleoverlevelsesforlöb indeholdende et CARD- og et kinasedomæne
BRPI0209416A8 (pt) novos vetores de expressão e uso dos mesmos
EE200000538A (et) TNF/NGF retseptoriperekonna retseptorite ja muudevalkude talitluse modulaatorid, nende valmistamine ja kasutamine ning farmatseutiline kompositsioon
FI960839A0 (fi) Uusia tripeptidejä, jotka ovat käyttökelpoisia immuuni- ja CNS-terapiassa
ES2132027A1 (es) Desarrollo de una piel artificial mediante cultivo de queratinocitos sobre una base de fibrina y fibroblastos humanos y metodo de preparacion de esta piel para trasplante.
DK72187A (da) Fremgangsmaade til modificering af lipidstrukturen, funktionen og udtrykkelsen af cellemembraber og farmaceutiske praeparater til anvendelse ved fremgangsmaaden
DE69636456D1 (de) In-vitro verpackung von adeno-assozierten virus dns
DK299590D0 (da) Phospholipidderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
DK240984D0 (da) 5-(4-chlor-3-sulfamoylbenzoyl)-2,3-dihydro-2-benzofurancarboxylsyrer,fremgangsmaader til deres fremstilling samt farmaceutiske praeparater indeholdende disse
DK352586D0 (da) 11-methylen-oestr-15-ener, fremgangsmaader til deres fremstilling og farmaceutiske praeparater indeholdende disse oestrener

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties